Sinocare Inc (300298) - Total Assets
Based on the latest financial reports, Sinocare Inc (300298) holds total assets worth CN¥6.25 Billion CNY (≈ $914.34 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Sinocare Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Sinocare Inc - Total Assets Trend (2008–2024)
This chart illustrates how Sinocare Inc's total assets have evolved over time, based on quarterly financial data. See shareholders equity of Sinocare Inc for net asset value and shareholders' equity analysis.
Sinocare Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Sinocare Inc's total assets of CN¥6.25 Billion consist of 39.1% current assets and 60.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 13.9% |
| Accounts Receivable | CN¥662.09 Million | 10.9% |
| Inventory | CN¥662.84 Million | 10.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥264.47 Million | 4.3% |
| Goodwill | CN¥1.13 Billion | 18.6% |
Asset Composition Trend (2008–2024)
This chart illustrates how Sinocare Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Sinocare Inc (300298) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sinocare Inc's current assets represent 39.1% of total assets in 2024, a decrease from 82.4% in 2008.
- Cash Position: Cash and equivalents constituted 13.9% of total assets in 2024, down from 36.5% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 0.0% in 2008.
- Asset Diversification: The largest asset category is goodwill at 18.6% of total assets.
Sinocare Inc Competitors by Total Assets
Key competitors of Sinocare Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
Sinocare Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.43 | 1.42 | 3.23 |
| Quick Ratio | 1.01 | 0.98 | 2.66 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥770.33 Million | CN¥649.97 Million | CN¥1.23 Billion |
Sinocare Inc - Advanced Valuation Insights
This section examines the relationship between Sinocare Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.79 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | 2.9% |
| Total Assets | CN¥6.10 Billion |
| Market Capitalization | $1.34 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Sinocare Inc's assets below their book value (0.22x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Sinocare Inc's assets grew by 2.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Sinocare Inc (2008–2024)
The table below shows the annual total assets of Sinocare Inc from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥6.10 Billion ≈ $892.27 Million |
+2.88% |
| 2023-12-31 | CN¥5.93 Billion ≈ $867.30 Million |
+28.37% |
| 2022-12-31 | CN¥4.62 Billion ≈ $675.63 Million |
+11.16% |
| 2021-12-31 | CN¥4.15 Billion ≈ $607.79 Million |
+6.61% |
| 2020-12-31 | CN¥3.90 Billion ≈ $570.10 Million |
+18.72% |
| 2019-12-31 | CN¥3.28 Billion ≈ $480.19 Million |
+9.38% |
| 2018-12-31 | CN¥3.00 Billion ≈ $439.00 Million |
+80.42% |
| 2017-12-31 | CN¥1.66 Billion ≈ $243.32 Million |
+12.84% |
| 2016-12-31 | CN¥1.47 Billion ≈ $215.62 Million |
+10.46% |
| 2015-12-31 | CN¥1.33 Billion ≈ $195.21 Million |
+10.09% |
| 2014-12-31 | CN¥1.21 Billion ≈ $177.32 Million |
+15.55% |
| 2013-12-31 | CN¥1.05 Billion ≈ $153.46 Million |
+10.83% |
| 2012-12-31 | CN¥946.27 Million ≈ $138.47 Million |
+292.35% |
| 2011-12-31 | CN¥241.18 Million ≈ $35.29 Million |
+64.70% |
| 2010-12-31 | CN¥146.44 Million ≈ $21.43 Million |
+105.50% |
| 2009-12-31 | CN¥71.26 Million ≈ $10.43 Million |
+142.87% |
| 2008-12-31 | CN¥29.34 Million ≈ $4.29 Million |
-- |
About Sinocare Inc
Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People's Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic disease… Read more